furegrelate has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
furegrelate: structure given in UD 35:175:d
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The cyclooxygenase inhibitor indomethacin reduces proteinuria in patients with focal segmental glomerulosclerosis (FSGS) or other glomerular diseases." | 7.71 | Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. ( McCarthy, ET; Sharma, M, 2002) |
| " The cyclooxygenase inhibitor indomethacin reduces proteinuria in patients with focal segmental glomerulosclerosis (FSGS) or other glomerular diseases." | 3.71 | Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. ( McCarthy, ET; Sharma, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCarthy, ET | 1 |
| Sharma, M | 1 |
1 other study available for furegrelate and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Albumins; Animals; Anti-Inflamma | 2002 |